SAN DIEGO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the third quarter ended September 30, 2025.

Q4 2025 Earnings Call Transcript November 14, 2025 Twist Bioscience Corporation beats earnings expectations. Reported EPS is ...

Summary The Siang Upper Multipurpose Project risks ecological disruption and cultural displacement in a fragile, seismic and biodiversity-rich zone. Climate and seismic risk assessments, along with ...

Structural variation refers to large scale structural differences in the genomic DNA that are inherited and polymorphic in a species. They are a result of chromosomal rearrangement – deletion, ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the third quarter ended September 30, 2025. "Over the last year, we have taken ...

Introduction The aetiology of eating disorders (EDs) is complex, involving an interplay of genetic and environmental factors.